People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Evogen, Inc. | — | Biotechnology | Seed | $1.9M | $37.9M | 2010 |
Thomas Jantsch at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Jantsch on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Levy | 1 | 10 |
| Jonathan Leitersdorf | 1 | 4 |
| Sean Reineke | 1 | 3 |
| Hans Kastensmith | 1 | 1 |
| Richard St. Clair | 1 | 1 |
| Robert Dondes | 1 | 1 |
| James Spigarelli | 1 | 1 |
| Nathan Ledeboer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.